Aims Contemporary data regarding atrial fibrillation (AF) management and current use of
oral anticoagulants (OACs) for stroke prevention are needed. Methods and results The …

Aims In recent years, stroke prevention in patients with atrial fibrillation (AF) has radically
changed, with increasing use of non-vitamin K antagonist oral anticoagulants (NOACs) …

Data on the management of atrial fibrillation (AF) in the Balkan Region are limited. The
Serbian AF Association (SAFA) prospectively investigated contemporary 'real-world'AF …

Objectives To describe (i) the trend in oral anticoagulant (OAC) use following the
introduction of non-vitamin K antagonist oral anticoagulant (NOAC) therapy for stroke …

Aim The aim of this study is to examine temporal trends in the use oral anticoagulants (OAC)
as stroke prophylaxis in patients with atrial fibrillation (AF) and to examine factors associated …

Background and Purpose—The purpose of this study was to investigate the impact of
improved antithrombotic treatment in atrial fibrillation after the introduction of non–vitamin K …

Objective To describe the changes in prescribing of oral anticoagulant (AC) and antiplatelet
(AP) agents in patients with non-valvular atrial fibrillation (NVAF) in the UK and to identify the …

Importance Vitamin K antagonist (eg, warfarin) use is nowadays challenged by the non–
vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation …

Background Recent improvements in atrial fibrillation diagnosis and management have
prompted the initiation of various registries, predominantly to assess adherence to new …

Objective Oral anticoagulant (OAC) prescription for stroke prevention in atrial fibrillation (AF)
patients frequently does not follow current guidelines, with underuse in patients at high risk …